OneMedNet Forms Strategic Partnership with Navidence to Boost Real-World Data Insights for Pharma
ONMD has more than doubled off its 52-week low of $0.3 on light trading volume (0.1× avg).
Summary
OneMedNet Corporation announced a strategic collaboration with Navidence to integrate Navidence's Computable Operational Definitions (CODefs) with OneMedNet's iRWD™ platform. This partnership is designed to empower pharmaceutical companies with more precise and actionable real-world data insights, streamlining study design, and accelerating evidence generation. For a company of OneMedNet's size, this collaboration is material as it enhances its product offering, promises efficiency gains and cost savings for clients, and aims to expand commercial opportunities in the growing real-world data market. Investors should monitor the successful integration of the platforms and the subsequent impact on customer acquisition and revenue growth.
At the time of this announcement, ONMD was trading at $0.83 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $38.9M. The 52-week trading range was $0.30 to $4.22. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.